logo
Company & Partnerships
You are here: Home » News » Company & Partnerships

LATEST NEWS

HKeyBio_NHP_Fast-Tox_Program_v2_1300_731.png
June 25, 2026
HKeyBio Launches NHP Fast-Tox Program for Accelerating Non-GLP NHP Safety Risk Screening

Read More
hkeybio_pressrelease_final_1300_731.png
June 10, 2026
HkeyBio Launches "NHP Fast-PoC" Program to Deliver Low-Cost Cyno PK/PD and Developability Data Amid Rising NHP Prices

Read More
ChatGPT Image 2026年5月26日 15_44_19_1485_835.png
May 27, 2026
Deepening Focus on Autoimmune Diseases, Empowering AI-Driven Drug Discovery

Read More
14ec1ae20b1d7003d8fdf8fbb6a12934_766_575.png
April 09, 2024
HKeybio to Participate in 2024 BIO: Showcasing Expertise in Autoimmune Disease Preclinical Models

San Diego, California, April 9, 2024 – HKeybio, the "Autoimmune Disease Model Expert" and a leading preclinical CRO exclusively focused on autoimmune and allergic diseases, officially announces its participation in the 2024 BIO International Convention & Exhibition. Held from June 3rd to 6th at the

Read More
HkeyBio is a China-based, globally-focused preclinical CRO dedicated exclusively to autoimmune and allergic diseases, with a unified service network across Asia, the Americas, Europe and Australia.

CONTACT US

Phone: +1 2396821165 / +86-512-67485716
Email: tech@hkeybio.com 
Suzhou HQ: 388 Xinping Street, Suzhou Industrial Park, Jiangsu, China 
Shanghai: 489 Yunchuan Road, Baoshan, Shanghai, China 
Nanning: Fazhan Avenue, Xixiangtang, Nanning, Guangxi, China 
Boston: 134 Coolidge Ave, Suite 2, Watertown, MA 02472, USA Melbourne: 432 St Kilda Rd, Melbourne, VIC 3004, Australia

QUICK LINKS

PRODUCTS CATEGORY

SIGN UP FOR OUR NEWSLETTER

Copyright © 2026 HkeyBio. All Rights Reserved.  Sitemap | Privacy Policy